Suhadolnik, R J, Peterson, D L, O'Brien, K et al. · Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 1997 · DOI
This study examined a specific immune system protein called RNase L in people with ME/CFS. Researchers found that people with ME/CFS had unusual forms of this protein that were different sizes and worked differently than those in healthy people, suggesting their antiviral defense system may be malfunctioning in a previously unknown way.
This study provides biochemical evidence that ME/CFS involves abnormalities in a key antiviral defense mechanism, offering a potential molecular explanation for viral-like symptoms and immune dysregulation. Understanding this pathway dysfunction could eventually lead to biomarkers for diagnosis or therapeutic targets for treatment.
This study does not prove that RNase L dysfunction causes ME/CFS, only that an association exists. It also does not establish whether the abnormal RNase L forms are pathogenic or compensatory responses to other primary dysfunction. The cross-sectional design prevents determination of whether these changes are primary disease drivers or secondary consequences.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →